Sanofi Winthrop Industrie

Sanofi Winthrop Industrie (France) holds 7 active US FDA Type II Drug Master Files and 2 inactive, has DMF or CEP filings on record for 17 active ingredients and is linked to 3 FDA-registered manufacturing sites. 13 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Sanofi Winthrop Industrie: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/sanofi-winthrop-industrie

Overview

Sanofi Winthrop Industrie is a subsidiary of Sanofi, a global biopharmaceutical company based in France. It is involved in the manufacturing and distribution of pharmaceutical products, focusing on improving patient care through innovation.

Core services & business areas

ManufacturingChemical DevelopmentQuality ControlPharmaceutical ManufacturingResearch and DevelopmentRegulatory AffairsSupply Chain Management

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Sanofi Winthrop Industrie holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Sanofi Winthrop Industrie holds 7 active (9 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • CABAZITAXEL ACETONE SOLVATEActive2010-01-29
  • RPR106721 - POMA (INTERMEDIATE)Active2009-12-15
  • ZOLPIDEM TARTRATEActive2007-10-30
  • DRONEDARONE HYDROCHLORIDEActive2005-06-08
  • CLOPIDOGREL BISULFATE FORM IIActive2000-03-31
  • PROMETHAZINE HCLActive1972-06-09
  • CHLORPROMAZINE HYDROCHLORIDEActive1970-04-23
  • CORDARONE (AMIODARONE HYDROCHLORIDE)Inactive1983-05-05
  • MANUFACTURING SITE, FACILITIES, PERSONNEL AND GENERAL OPERATING PROCEDURES IN AMBARES, FRANCE.Inactive1983-04-25

Registered manufacturing sites (3)

Physical sites registered with the US FDA and resolved to Sanofi Winthrop Industrie, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

13 FDA enforcement records linked to this company.

  • 4832024-01-26

    Validation lacking for sterile drug products

  • 4832024-01-26

    Equipment Design, Size and Location

  • 4832024-01-26

    Procedures not in writing, fully followed

  • 4832024-01-26

    Buildings of Suitable Size, Construction, Location

  • 4832018-06-15

    Procedures not in writing, fully followed

  • 4832016-10-31

    Changes to Procedures Not Reviewed, Approved

  • 4832016-10-31

    Training , Education , Experience overall

  • 4832016-10-31

    Test methods

  • 4832012-09-18

    Procedures for sterile drug products

  • 4832012-09-18

    Cleaning / Sanitizing / Maintenance

  • 4832012-09-18

    Validation lacking for sterile drug products

  • 4832012-09-18

    Defined areas of adequate size for operations

  • 4832012-09-18

    Investigations of discrepancies, failures

For suppliers

Is this Sanofi Winthrop Industrie?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.